The Board of Directors is a very valuable resource for Medicon Valley Alliance. The Directors represent the entire value chain that is Life Science and in many ways the MVA Board of Directors embodies the unique network that is Medicon Valley Alliance.
MVA's Board of Directors consists of a unique combination of Danish and Swedish representatives from private and public research organizations, academia and regional governments, as well as SME's and large international companies covering biotech, pharma, and medtech.
![]() |
Bo AhrénChairman of the Board |
![]() |
Mikael ØrumVice Chairman of the Board |
![]() |
Per BennetsenExecutive Director, Region Sealand |
![]() |
Klaus Peter BøgesøVice President of External Affairs, H. Lundbeck A/S |
![]() |
Naser EftekharianSenior Advisor to the Vice-Chancellor, Malmö University |
![]() |
Sven FrøkjærDean, Faculty of Pharmaceutical Sciences, University of Copenhagen |
![]() |
Jannik HilstedChief Medical Officer, Rigshospitalet, Copenhagen University Hospital |
![]() |
Thomas HögbergSenior Scientific Advisor, LEO Pharma A/S |
![]() |
Kim HøghGroup Managing Director, Capital Region of Denmark |
![]() |
Ida Sofie JensenKoncernchef, Lægemiddelindustriforeningen Danmark |
![]() |
Peter KurtzhalsSenior Vice President, Novo Nordisk A/S |
![]() |
Håkan LarssonSweden Science Relations Lead, AstraZeneca R&D Mölndal |
![]() |
Ulf LindahlDirector Nordics & Baltics Chronic sales, Gambro Lundia AB |
![]() |
Mikael StammingUtvecklingsdirektör, Region Skåne |
![]() |
Fredrik TibergPresident and CEO, Camurus AB |
![]() |
Marianne ThellermannVice Chairman of the Board |
![]() |
Gunilla Westergren-ThorssonDean of the Faculty of Medicine, Lund University |

















